Pfizer Contemplates $2 Billion Acquisition of Strides’ Agila Unit

News   Jan 17, 2013

 
Pfizer Contemplates $2 Billion Acquisition of Strides’ Agila Unit
 
 
 

RELATED ARTICLES

Discovery of Exomeres Could Help Reveal How Cancer Cells Spread

News

A new cellular messenger discovered by Weill Cornell Medicine scientists may help reveal how cancer cells co-opt the body's intercellular delivery service to spread to new locations in the body.

READ MORE

Evolution Threatens Efficient Bioproduction Scale-Up

News

The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.

READ MORE

Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

News

Rapid evolution can suppress the effect of pro-production genes in biochemical processes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE